0H68 Stock Chart & Stats
$126.33
$0.23(0.18%)
At close: 4:00 PM EDT
$126.33
$0.23(0.18%)
Day’s Range― - ―
52-Week Range$104.30 - $130.95
Previous CloseN/A
Volume4.00
Average Volume (3M)1.20K
Market Cap
$58.45B
Enterprise Value$68.01K
Total Cash (Recent Filing)$93.65B
Total Debt (Recent Filing)$8.73B
Price to Earnings (P/E)12.5
Beta0.62
Next Earnings
Nov 04, 2026EPS Estimate
1.8Next Dividend Ex-DateN/A
Dividend Yield2.07%
Share Statistics
EPS (TTM)9.32
Shares Outstanding501,343,300
10 Day Avg. Volume1,023
30 Day Avg. Volume1,202
Financial Highlights & Ratios
PEG Ratio-0.55
Price to Book (P/B)1.98
Price to Sales (P/S)3.35
P/FCF Ratio22.88
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$116.10Price Target Upside-8.10% Downside
Rating ConsensusHold
Number of Analyst Covering11
EPS Forecast (FY)7.01
Revenue Forecast (FY)$16.69B
Bulls Say, Bears Say
Bulls Say
High Profitability And MarginsSustained high TTM margins and mid-teens ROE indicate durable underwriting discipline and pricing power in supplemental insurance. Strong margins provide recurring earnings cushion versus claims variability and support reinvestment, dividends, and buybacks over the medium term.
Conservative Capital Position And Capital ReturnsRobust regulatory capital (ESR ~226%), combined RBC above 600% and adjusted leverage within target, underpins solvency and regulatory flexibility. The strong capital base enables consistent shareholder returns and strategic portfolio actions without impairing reserve adequacy or growth investments.
Product And Distribution Momentum With Strong PersistencyNew product traction in Japan and accelerating U.S. group/dental channels, plus high persistency (Japan 92.7%, U.S. 79.4%), support recurring premium streams and cross-sell potential. Durable distribution relationships and sticky policies help stabilize long-term premium revenue.
Bears Say
Weak Top-line MomentumA sharp TTM revenue decline signals deteriorating premium growth dynamics that could constrain long-term earnings leverage. Even with margin resilience, persistent top-line weakness complicates growth targets, increases reliance on investment income, and pressures future underwriting scale.
Weakening Free Cash Flow GrowthAlthough FCF equals reported net income today, sharply negative FCF growth implies deteriorating cash generation trends. Slowing FCF limits flexibility for buybacks, dividends, or reinvestment and raises sensitivity to adverse claims, investment returns, or capital actions over the medium term.
Cybersecurity Incident In Aflac JapanA confirmed breach affecting customer and bank data creates potential for regulatory enforcement, remediation costs, and reputational damage in Aflac's largest market. Persistent regulatory scrutiny and remediation can raise compliance costs and hinder distribution partnerships over several quarters.
AFLAC News
0H68 FAQ
What was AFLAC’s price range in the past 12 months?
AFLAC lowest share price was $104.30 and its highest was $130.95 in the past 12 months.
What is AFLAC’s market cap?
AFLAC’s market cap is $58.45B.
When is AFLAC’s upcoming earnings report date?
AFLAC’s upcoming earnings report date is Nov 04, 2026 which is in 67 days.
How were AFLAC’s earnings last quarter?
AFLAC released its earnings results on Aug 06, 2026. The company reported $1.75 earnings per share for the quarter, missing the consensus estimate of $1.764 by -$0.014.
Is AFLAC overvalued?
According to Wall Street analysts AFLAC’s price is currently Overvalued.
Does AFLAC pay dividends?
AFLAC pays a Quarterly dividend of $0.61 which represents an annual dividend yield of 2.07%. See more information on AFLAC dividends here
What is AFLAC’s EPS estimate?
AFLAC’s EPS estimate is 1.8.
How many shares outstanding does AFLAC have?
AFLAC has 501,343,300 shares outstanding.
What happened to AFLAC’s price movement after its last earnings report?
AFLAC reported an EPS of $1.75 in its last earnings report, missing expectations of $1.764. Following the earnings report the stock price went down -1.353%.
Which hedge fund is a major shareholder of AFLAC?
Currently, no hedge funds are holding shares in GB:0H68
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
AFLAC Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$116.10 (-8.10% Downside)
$116.10 (-8.10% Downside)
Blogger Sentiment
Neutral
GB:0H68 Sentiment 73%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth $69.4M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
25.21%
12-Months-Change
Fundamentals
Return on Equity
2.07%
Trailing 12-Months
Asset Growth
-7.27%
Trailing 12-Months
Company Description
AFLAC
Aflac Incorporated, operating through its various subsidiary companies, focuses on delivering supplementary health and life insurance policies. The firm's business activities are structured into two primary divisions: Aflac Japan and Aflac U.S. In Japan, the company offers a diverse range of insurance products, including coverage for cancer, medical expenses, income support for nursing care, and the distinct GIFT plan. This segment also provides traditional whole and term life insurance, along with savings-oriented plans like WAYS and child endowment products. Meanwhile, the Aflac U.S. division caters to the American market, furnishing policies that address cancer, accidents, short-term disability, critical illness, and hospital stays. Additionally, it provides dental, vision, long-term care, disability, and both term and whole life insurance options. Aflac distributes its comprehensive suite of products through multiple channels, which include dedicated sales associates, independent brokers, various corporate and individual agencies, and affiliated agencies. Established in 1955, the company maintains its corporate headquarters in Columbus, Georgia.
0H68 Company Deck
0H68 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a generally positive tone: management highlighted solid capital ratios, strong shareholder returns, active investment portfolio repositioning expected to boost recurring income, and product momentum in both Japan (Tsumitasu, Anshin Palette) and U.S. group/dental & vision channels. Offsetting issues were modest — near-term sales comparisons in Japan versus a strong 2025 quarter, a small decline in adjusted book value per share, some investment income shortfalls, elevated lapse/reissue activity on new Japan products and higher U.S. group disability claims. Management maintained constructive outlooks for capital deployment, reserve/reinsurance actions and premium growth (2025–2027 net earned premium CAGR guidance of 3%–6%), suggesting that positives outweigh the contained challenges.View all GB:0H68 earnings summaries0H68 Revenue Breakdown
54.52% Aflac Japan
40.22% Aflac U.S.
7.44% Corporate and other
-3.33% Net investment
0.26% Amortized hedge costs
-0.57% Amortized hedge income
1.47% Net interest (income) expense from derivatives associated with certain investment strategies
0H68 Stock 12 Month Forecast
Average Price Target
$116.10
▼(-8.10% Downside)